Clinical Trial Update: Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating once-daily darunavir/ritonavir as a simplification strategy for antiretroviral therapy in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: COMPLETED